Casandra
Casandra Test Code NG65327Version 1 (DRAFT)
Performing Lab
AML MRD Flow Panel
Clinical Use
Order TestUse
MRD assessment has the potential to improve outcomes for patients with acute myeloid leukemia (AML). This assay is designed to detect MRD at a sensitivity level of 0.01%.
Special Instructions
This assay is available as a Global test only. New York State samples must be received within 48 hours from collection per NYS requirements.
Limitations
Samples must be received within specified timeframes to assure cell viability and analysis. Lithium heparin or ACD tubes are not acceptable.
Test Details
New York Approved
Methodology
Cell-based / Cytometry (Flow Cytometry)
Biomarkers
20 targets
CD117CD11bCD13CD14CD15CD16CD19CD2+12 more
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Bone Marrow
Volume
2-3 mL
Minimum Volume
Not provided
Container
EDTA preferred. Sodium heparin tube acceptable.
Collection Instructions
First pull.
Storage Instructions
Refrigerate specimen. Do not freeze.
Causes for Rejection
Lithium heparin or ACD (pale yellow/no gel separator) not acceptable.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | Specimens should be received within 72 hours from collection. New York State samples within 48 hours. |